Plexus Corp. (NASDAQ:PLXS) CFO Patrick John Jermain Sells 4,328 Shares

Plexus Corp. (NASDAQ:PLXS) CFO Patrick John Jermain sold 4,328 shares of the business’s stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $132.29, for a total transaction of $572,551.12. Following the completion of the transaction, the chief financial officer now owns 25,637 shares of the company’s stock, valued at $3,391,518.73. The trade was a 14.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Plexus Price Performance

Shares of NASDAQ PLXS traded down $1.33 during midday trading on Monday, reaching $132.95. 100,156 shares of the company were exchanged, compared to its average volume of 168,630. The stock’s 50-day moving average price is $124.90 and its 200-day moving average price is $143.02. The stock has a market cap of $3.60 billion, a P/E ratio of 30.85 and a beta of 0.80. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a one year low of $100.96 and a one year high of $172.89.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.12. The business had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. Plexus’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.94 EPS. On average, sell-side analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Stifel Nicolaus set a $145.00 target price on Plexus in a research note on Thursday, April 24th. Benchmark reissued a “buy” rating and set a $160.00 price target on shares of Plexus in a report on Friday. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $162.00 price objective (down from $172.00) on shares of Plexus in a research note on Friday, April 25th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $155.67.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in Plexus by 0.6% during the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company’s stock worth $125,005,000 after buying an additional 6,257 shares during the period. Pacer Advisors Inc. bought a new position in shares of Plexus during the fourth quarter valued at $107,489,000. American Century Companies Inc. lifted its holdings in shares of Plexus by 24.7% during the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company’s stock worth $86,901,000 after purchasing an additional 134,205 shares during the period. Nuveen Asset Management LLC grew its stake in shares of Plexus by 6.6% in the fourth quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company’s stock worth $55,012,000 after purchasing an additional 21,911 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in Plexus by 120.4% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock valued at $44,655,000 after purchasing an additional 190,360 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.